$NLNK Recent News Sarepta says its Ebola drug
Post# of 102254
Posted On: 10/20/2014 11:18:33 AM
$NLNK Recent News
Sarepta says its Ebola drug has no ill effects 5:28 p.m. Oct. 16, 2014 - Russ Britt
Two biotechs staking claim in fight against Ebola 4:06 p.m. Oct. 16, 2014 - Russ Britt
Is there an Ebola bubble in these stocks? 3:22 p.m. Oct. 16, 2014 - Wallace Witkowski
AMD shares drop after hours 6:51 p.m. Oct. 13, 2014 - Wallace Witkowski
Fight against Ebola spreads to other nations 4:42 p.m. Oct. 13, 2014 - Russ Britt
Newlink shares jump on start of Ebola vaccine study 4:14 p.m. Oct. 13, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
Ebola vaccine use likely to be confined, experts say 7:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 4:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 4:14 p.m. Oct. 3, 2014 - Russ Britt
Tesla climbs on product hint; Constellation falls 8:07 a.m. Oct. 2, 2014 - Ben Eisen
Getting Ebola treatments to market may take time 3:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 8:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Ben Eisen
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
9 IPOs on tap; Angie's List, Delphi lead 2:11 p.m. Nov. 12, 2011 - MarketWatch.com
Why NewLink Genetics (NLNK) Stock Is Soaring Today 37 min ago - TheStreet.com
Heavy Trading On NewLink Genetics (NLNK) Before Market Open 9:16 a.m. Today - TheStreet.com
New Link Genetics and Genentech team up in cancer immunotherapy 7:51 a.m. Today - Seeking Alpha
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement For Development Of NLG919, An IDO Inhibitor In Phase 1, And Research Collaboration For The Discovery Of Next Generation IDO/TDO Inhibitors 6:01 a.m. Today - benzinga.com
Ebola Vaccine Push Ramps Up 7:54 p.m. Oct. 19, 2014 - The Wall Street Journal Interactive Edition
Canada Ships Out Experimental Ebola Vaccine 4:28 p.m. Oct. 18, 2014 - The Wall Street Journal Interactive Edition
Stomach-Churning Ride for Ebola Stocks 2:52 p.m. Oct. 17, 2014 - FOXBusiness
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog 2:34 p.m. Oct. 17, 2014 - Zacks.com
Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback 1:50 p.m. Oct. 17, 2014 - TheStreet.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/16/14 6:00 p.m. Oct. 16, 2014 - FOXBusiness
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Stock To Watch: NewLink Genetics (NLNK) In Perilous Reversal 10:11 a.m. Oct. 14, 2014 - TheStreet.com
NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape 9:46 a.m. Oct. 14, 2014 - Zacks.com
Canada Launches Clinical Trials of Ebola Vaccine 1:54 p.m. Oct. 13, 2014 - The Wall Street Journal Interactive Edition
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
Trade-Ideas: NewLink Genetics (NLNK) Is Today's Strong On High Relative Volume Stock 10:02 a.m. Oct. 10, 2014 - TheStreet.com
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 8:22 a.m. Today - eTeligis
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - GlobeNewswire
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - Marketwired
Critical Alerts For NewLink Genetics, Orexigen Therapeutics, JinkoSolar, Randgold Resources and Arrowhead Research Released By InvestorsObserver 9:31 a.m. Oct. 16, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NewLink Genetics Corporation - NLNK 1:55 p.m. Oct. 2, 2014 - PR Newswire - PRF
Critical Alerts For AT&T, NewLink Genetics, Acuity Brands, Quintiles and Finish Line Released By InvestorsObserver 9:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:22 p.m. Oct. 1, 2014 - Marketwire
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:14 p.m. Oct. 1, 2014 - eTeligis
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:16 a.m. Sept. 4, 2014 - Marketwire
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:01 a.m. Sept. 4, 2014 - eTeligis
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:01 a.m. Aug. 5, 2014 - eTeligis
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:17 p.m. Aug. 4, 2014 - eTeligis
NewLink Genetics to Present at the XVIth International Congress of Virology 7:15 a.m. July 28, 2014 - Marketwire
NewLink Genetics to Present at the XVIth International Congress of Virology 7:00 a.m. July 28, 2014 - eTeligis
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress at ASCO 2014 Annual Meeting 2:35 a.m. June 5, 2014 - Marketwire
NewLink Genetics Dorgenmeltucel-L HyperAcute Immunotherapy for Melanoma Demonstrates Clinical Efficacy With Tumor Regression and Immune Activation 7:11 a.m. May 30, 2014 - Marketwire
Sarepta says its Ebola drug has no ill effects 5:28 p.m. Oct. 16, 2014 - Russ Britt
Two biotechs staking claim in fight against Ebola 4:06 p.m. Oct. 16, 2014 - Russ Britt
Is there an Ebola bubble in these stocks? 3:22 p.m. Oct. 16, 2014 - Wallace Witkowski
AMD shares drop after hours 6:51 p.m. Oct. 13, 2014 - Wallace Witkowski
Fight against Ebola spreads to other nations 4:42 p.m. Oct. 13, 2014 - Russ Britt
Newlink shares jump on start of Ebola vaccine study 4:14 p.m. Oct. 13, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
Ebola vaccine use likely to be confined, experts say 7:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 4:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 4:14 p.m. Oct. 3, 2014 - Russ Britt
Tesla climbs on product hint; Constellation falls 8:07 a.m. Oct. 2, 2014 - Ben Eisen
Getting Ebola treatments to market may take time 3:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 8:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Ben Eisen
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
9 IPOs on tap; Angie's List, Delphi lead 2:11 p.m. Nov. 12, 2011 - MarketWatch.com
Why NewLink Genetics (NLNK) Stock Is Soaring Today 37 min ago - TheStreet.com
Heavy Trading On NewLink Genetics (NLNK) Before Market Open 9:16 a.m. Today - TheStreet.com
New Link Genetics and Genentech team up in cancer immunotherapy 7:51 a.m. Today - Seeking Alpha
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement For Development Of NLG919, An IDO Inhibitor In Phase 1, And Research Collaboration For The Discovery Of Next Generation IDO/TDO Inhibitors 6:01 a.m. Today - benzinga.com
Ebola Vaccine Push Ramps Up 7:54 p.m. Oct. 19, 2014 - The Wall Street Journal Interactive Edition
Canada Ships Out Experimental Ebola Vaccine 4:28 p.m. Oct. 18, 2014 - The Wall Street Journal Interactive Edition
Stomach-Churning Ride for Ebola Stocks 2:52 p.m. Oct. 17, 2014 - FOXBusiness
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog 2:34 p.m. Oct. 17, 2014 - Zacks.com
Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback 1:50 p.m. Oct. 17, 2014 - TheStreet.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/16/14 6:00 p.m. Oct. 16, 2014 - FOXBusiness
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Stock To Watch: NewLink Genetics (NLNK) In Perilous Reversal 10:11 a.m. Oct. 14, 2014 - TheStreet.com
NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape 9:46 a.m. Oct. 14, 2014 - Zacks.com
Canada Launches Clinical Trials of Ebola Vaccine 1:54 p.m. Oct. 13, 2014 - The Wall Street Journal Interactive Edition
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
Trade-Ideas: NewLink Genetics (NLNK) Is Today's Strong On High Relative Volume Stock 10:02 a.m. Oct. 10, 2014 - TheStreet.com
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 8:22 a.m. Today - eTeligis
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - GlobeNewswire
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - Marketwired
Critical Alerts For NewLink Genetics, Orexigen Therapeutics, JinkoSolar, Randgold Resources and Arrowhead Research Released By InvestorsObserver 9:31 a.m. Oct. 16, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NewLink Genetics Corporation - NLNK 1:55 p.m. Oct. 2, 2014 - PR Newswire - PRF
Critical Alerts For AT&T, NewLink Genetics, Acuity Brands, Quintiles and Finish Line Released By InvestorsObserver 9:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:22 p.m. Oct. 1, 2014 - Marketwire
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:14 p.m. Oct. 1, 2014 - eTeligis
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:16 a.m. Sept. 4, 2014 - Marketwire
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:01 a.m. Sept. 4, 2014 - eTeligis
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:01 a.m. Aug. 5, 2014 - eTeligis
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:17 p.m. Aug. 4, 2014 - eTeligis
NewLink Genetics to Present at the XVIth International Congress of Virology 7:15 a.m. July 28, 2014 - Marketwire
NewLink Genetics to Present at the XVIth International Congress of Virology 7:00 a.m. July 28, 2014 - eTeligis
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress at ASCO 2014 Annual Meeting 2:35 a.m. June 5, 2014 - Marketwire
NewLink Genetics Dorgenmeltucel-L HyperAcute Immunotherapy for Melanoma Demonstrates Clinical Efficacy With Tumor Regression and Immune Activation 7:11 a.m. May 30, 2014 - Marketwire
(0)
(0)Scroll down for more posts ▼